Enanta Pharmaceuticals (ENTA) Tax Rate (2014 - 2026)
Enanta Pharmaceuticals' (ENTA) quarterly Tax Rate came in at 0.05% in Q1 2026, down 550.0% YoY from 0.01% in Q1 2025, and up 73.44% on a QoQ basis from 0.2% in Q4 2025.
Analysis
Enanta Pharmaceuticals (ENTA) Tax Rate (2014 - 2026) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 13 years of Tax Rate data on file, last reported at 0.05% in Q1 2026.
- Quarterly Tax Rate fell 550.0% year-over-year to 0.05% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.15% (down 266.0% YoY) and the FY2025 annual result came in at 1.99%, up 51.0% from the prior year.
- Tax Rate improved to 0.05% in Q1 2026, from 0.2% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 13.32% in Q3 2023 to a low of 12.11% in Q2 2023.
- A 5-year average of 0.95% and a median of 0.63% in 2022 frame the typical range for Tax Rate.
- The widest YoY moves for Tax Rate: up 14521 bps in 2022, down 2670 bps in 2022.
- Tracing ENTA's Tax Rate over 5 years: stood at 0.12% in 2022, then surged by 1460 bps to 1.83% in 2023, then gained by 0 bps to 1.83% in 2024, then sank by 111 bps to 0.2% in 2025, then surged by 73 bps to 0.05% in 2026.
- The last three Tax Rate figures came in at 0.05% (Q1 2026), 0.2% (Q4 2025), and 0.17% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -16.71% |
| 10 | Enanta Pharmaceuticals | 408.71 Mn | 219.21 Mn | - | -0.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18% |
| Mar 31, 2026 | -0.05% |
| Dec 31, 2025 | -0.20% |
| Sep 30, 2025 | 0.43% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | 5.45% |
| Dec 31, 2024 | 1.83% |
| Sep 30, 2024 | 1.91% |
| Jun 30, 2024 | 1.71% |
| Mar 31, 2024 | 1.15% |
| Dec 31, 2023 | 1.83% |
| Sep 30, 2023 | 4.78% |
| Jun 30, 2023 | -12.11% |
| Mar 31, 2023 | -0.12% |
| Dec 31, 2022 | 0.12% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | 1.39% |
| Dec 31, 2021 | 0.12% |
| Sep 30, 2021 | 26.75% |
| Jun 30, 2021 | 28.09% |